[Federal Register Volume 66, Number 42 (Friday, March 2, 2001)]
[Notices]
[Page 13082]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-5061]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Biotransplant, Inc.

    Notice is hereby given that, on January 12, 2001, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Biotransplant, Inc. has 
filed written notifications simultaneously with the Attorney General 
and the Federal Trade Commission disclosing (1) the identities of the 
parties and (2) the nature and objectives of the venture. The 
notifications were filed for the purpose of invoking the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances.
    Pursuant to section 6(b) of the Act, the identities of the parties 
are Immerge BioTherapeutics, Charlestown, MA; and Infigen, Inc., 
DeForest, WI. The nature and objectives of the venture are to conduct 
research on the genetic modification of pigs by nuclear transfer 
technology.

Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 01-5061 Filed 3-1-01; 8:45 am]
BILLING CODE 4410-11-M